Patents by Inventor Marc Elsayed

Marc Elsayed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8589188
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a fetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to fetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: November 19, 2013
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Publication number: 20120232922
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 13, 2012
    Inventors: Marc Elsayed, Bruce Williams
  • Patent number: 8204763
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: June 19, 2012
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Publication number: 20110082706
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Application
    Filed: December 13, 2010
    Publication date: April 7, 2011
    Inventors: Marc Elsayed, Bruce Williams
  • Patent number: 7874984
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: April 12, 2005
    Date of Patent: January 25, 2011
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Publication number: 20050215869
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Application
    Filed: April 12, 2005
    Publication date: September 29, 2005
    Applicant: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Patent number: 6908432
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: June 21, 2005
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Publication number: 20040152960
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Application
    Filed: January 22, 2004
    Publication date: August 5, 2004
    Applicant: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Patent number: 6767326
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: July 27, 2004
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Publication number: 20030158469
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Application
    Filed: March 7, 2003
    Publication date: August 21, 2003
    Inventors: Marc Elsayed, Bruce Williams
  • Patent number: 6561976
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: September 26, 2001
    Date of Patent: May 13, 2003
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams
  • Publication number: 20020016532
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Application
    Filed: September 26, 2001
    Publication date: February 7, 2002
    Inventors: Marc Elsayed, Bruce Williams
  • Patent number: 6045501
    Abstract: Novel methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug. Embodiments are provided in which the involved prescribers, pharmacies and patients are registered in one or more computer databases. Embodiments are also provided in which registered patients receive counseling information concerning the risks attendant to foetal exposure to the drug. Male patients and female patients who are not pregnant may, in certain circumstances, receive the drug.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: April 4, 2000
    Assignee: Celgene Corporation
    Inventors: Marc Elsayed, Bruce Williams